NCT07214493

Brief Summary

Most prosthetic feet have a fixed heel height, which requires users to always wear shoes with the same heel height. A fixed heel height is a significant constraint, whereas the ability to choose one's clothing freely is an important aspect of coping with a physical disability. The Taleo Adjust is a prosthetic foot with a hydraulic ankle that allows the user to adjust the heel height from 0 to 7 cm, depending on the type of shoe worn. This study aims to evaluate the impact of an adjustable-heel-height foot on physical appearance and participation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Oct 2025Jun 2026

First Submitted

Initial submission to the registry

September 23, 2025

Completed
15 days until next milestone

Study Start

First participant enrolled

October 8, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 9, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 6, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2026

Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

8 months

First QC Date

September 23, 2025

Last Update Submit

November 20, 2025

Conditions

Keywords

Lower limb amputationProsthetic footAdjustable heel heightHydraulic ankle

Outcome Measures

Primary Outcomes (1)

  • Prosthetic Evaluation Questionnaire - Appearance scale (PEQ-AP)

    A 5-item self-reported measure of the appearance domain. The participant rates each item by marking a 100-mm line. Scores range from 0 to 100, with higher scores indicating a more positive perception.

    30 days

Secondary Outcomes (7)

  • Patient Specific functional Scale (PSFS)

    30 days

  • Psychosocial Impact of Assistive Device Scale (PIADS)

    30 days

  • Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0)

    30 days

  • Visual Analog Scale (VAS) for the adequacy to life's project

    30 days

  • EuroQuol - 5 Dimensions - 5 Levels (EQ-5D-5L)

    30 days

  • +2 more secondary outcomes

Study Arms (2)

Taleo Adjust foot then usual foot

OTHER

The participant is first fitted with the Taleo Adjust foot for 30 days, then is fitted with their usual foot for 30 days.

Device: Taleo AdjustDevice: The usual participant's foot

Usual foot then taleo Adjust foot

OTHER

The participant is first fitted with their usual foot for 30 days, then fitted with the Taleo Adjust foot for 30 days

Device: Taleo AdjustDevice: The usual participant's foot

Interventions

The Taleo Adjust foot is an energy-storage-and-return (ESR) prosthetic foot with a hydraulic ankle joint that allows an adjustable heel height from 0 to 7 cm.

Taleo Adjust foot then usual footUsual foot then taleo Adjust foot

The usual foot of the participant is an Energy Storage and Return (ESR) prosthetic foot (no heel height adjustement)

Taleo Adjust foot then usual footUsual foot then taleo Adjust foot

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient with a major lower limb amputation whose life project includes:
  • movement in buildings other than the home (ICF d4601),
  • movement outside the home and other buildings (ICF d4602),
  • and other specified activities related to movement in other various places (ICF d4608).
  • Patient who has been using an Enregy storage and Return (ESR) foot for at least 3 months
  • Patient who wishes to walk with shoes with different heel heights, and/or barefoot

You may not qualify if:

  • Patient with a high impact level (e.g.: sport)
  • Patient with hip disarticulation or equivalent
  • Patient with an unstabilised residual limb and/or an unsuitable socket
  • Patient who cannot be fitted with a Taleo Adjust foot due to the technical characteristics of the product (user weight greater than 115kg; required foot size \<22 or \>28; mounting height less than 118 mm)
  • Patient whose usual foot has a heel height adjustment system
  • Patient unavailable for the duration of the study and/or unable to understand the instructions and/or answer questionnaires in French
  • Patient already participating in another study
  • Patient in an emergency situation or pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

CH Cornouaille

Concarneau, France

RECRUITING

CHU Grenoble

Échirolles, France

RECRUITING

IRR Louis Pierquin

Nancy, France

RECRUITING

CRRF La Tourmaline

Saint-Herblain, France

RECRUITING

Institut Merle d'Aubigné

Valenton, France

RECRUITING

Study Officials

  • Brice LAVRARD, Dr.

    Institut Merle d'Aubigné - VALENTON

    STUDY CHAIR
  • Isabelle LOIRET

    IRR Louis Pierquin - NANCY

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2025

First Posted

October 9, 2025

Study Start

October 8, 2025

Primary Completion (Estimated)

June 6, 2026

Study Completion (Estimated)

June 6, 2026

Last Updated

November 25, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations